Transparency research shows that when authors make data and analysis code available, reproducibility and trust increase and that benefits everyone, from clinicians making prescribing decisions to patients evaluating risks
Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist that works by mimicking a naturally occurring hormone responsible for regulating appetite and blood sugar
Continuous treatment also provides sustained improvements in cardiometabolic risk factors, including hemoglobin A1c, blood pressure, and lipid profiles
[4] [5] [6] Finasteride Finasteride is a 5-alpha reductase inhibitor used to treat symptomatic benign prostatic hyperplasia (BPH), a condition found in the majority of men over the age of 50
Reference: Ueda P, Sderling J, Wintzell V, et al